Search Results 631-640 of 18126 for sd

  1. Pituitary Tumors Specialty Group - Overview - Mayo Clinic

    Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and ...

  2. Atrial fibrillation - Care at Mayo Clinic

    Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and ...

  3. Neuroimmunology - Overview - Mayo Clinic

    Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and ...

  4. Balance problems - Care at Mayo Clinic

    Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and ...

  5. Chest Pain and Coronary Physiology Clinic - Overview

    Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and ...

  6. Heart Health and Performance Program in Arizona - Overview - Mayo Clinic

    Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and ...

  7. Surgery - Conditions treated - Mayo Clinic

    Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and ...

  8. Collaborators - Neural Engineering and Precision Surgery: Kendall H. Lee

    ... South Dakota State University. Malcolm B. McIntosh, M.S.. McIntosh is section head of technology development in the Division of Engineering. He is the ...

  9. Castleman disease - Symptoms and causes - Mayo Clinic

    This rare disorder involves an overgrowth of cells in your body's lymph nodes. Treatment varies depending on how many lymph nodes are involved.

  10. Sym021 in Combination with Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients with Advanced Biliary Tract Carcinomas - Mayo Clinic

    Patients must have a best response of CR/PR or durable SD (defined as ≥ 3 months duration of SD) on prior anti-PD-(L)1 therapy. Patients with mixed ...